Javascript must be enabled to continue!
Quantitation of estradiol by competitive light‐initiated chemiluminescent assay using estriol as competitive antigen
View through CrossRef
Abstract
Background
Light‐initiated chemiluminescent assays (LICA) are homogeneous assays that are sensitive, specific, and free of separation and washing steps and have high throughput and high precision.
Methods
In this research, we developed a competitive method by LICA to achieve accurate quantification of estradiol (E2) in human serum. E2 competed with estriol (E3) for binding to anti‐human E2 antibodies. E3 was linked to biotin via bovine serum albumin as a linker. As this assay used competition between the labeled tracer and the analyte, an increase in E2 concentration will cause a signal decrease.
Results
The expected detection range of E2 was 20‐5000 pg/mL. The analytical and functional sensitivities were 7.16 and 13.7 pg/mL, respectively. The intra‐ and inter‐assay coefficients of variation were both below 15%, and the recovery rate ranged from 97.5% to 106.8%. The interference rates ranged from −3.6% to 5.4% and met detection requirements for E2 in hyperbilirubinemia, hemolysis, and lipemia in clinical samples. In addition, the cross‐reactivity rates between E2 and structural analogs and some reproductive hormones varied from 1.9% to 10.6% which showed that LICA is highly specific for E2. Moreover, our results showed high accordance with the IMMULITE 2000 (
y
= 0.6695
x
+ 47.92,
r
2
= .843) and VIDAS systems (
y
= 1.099
x
− 821.5,
r
2
= .9392).
Conclusion
Our data show that the LICA, which is easy to automate, is a promising technique for quantification of E2 in human serum and could be used for clinical detection.
Title: Quantitation of estradiol by competitive light‐initiated chemiluminescent assay using estriol as competitive antigen
Description:
Abstract
Background
Light‐initiated chemiluminescent assays (LICA) are homogeneous assays that are sensitive, specific, and free of separation and washing steps and have high throughput and high precision.
Methods
In this research, we developed a competitive method by LICA to achieve accurate quantification of estradiol (E2) in human serum.
E2 competed with estriol (E3) for binding to anti‐human E2 antibodies.
E3 was linked to biotin via bovine serum albumin as a linker.
As this assay used competition between the labeled tracer and the analyte, an increase in E2 concentration will cause a signal decrease.
Results
The expected detection range of E2 was 20‐5000 pg/mL.
The analytical and functional sensitivities were 7.
16 and 13.
7 pg/mL, respectively.
The intra‐ and inter‐assay coefficients of variation were both below 15%, and the recovery rate ranged from 97.
5% to 106.
8%.
The interference rates ranged from −3.
6% to 5.
4% and met detection requirements for E2 in hyperbilirubinemia, hemolysis, and lipemia in clinical samples.
In addition, the cross‐reactivity rates between E2 and structural analogs and some reproductive hormones varied from 1.
9% to 10.
6% which showed that LICA is highly specific for E2.
Moreover, our results showed high accordance with the IMMULITE 2000 (
y
= 0.
6695
x
+ 47.
92,
r
2
= .
843) and VIDAS systems (
y
= 1.
099
x
− 821.
5,
r
2
= .
9392).
Conclusion
Our data show that the LICA, which is easy to automate, is a promising technique for quantification of E2 in human serum and could be used for clinical detection.
Related Results
Estriol: emerging clinical benefits
Estriol: emerging clinical benefits
AbstractObjective:Estriol is the main estrogen in pregnancy, but has received less attention outside gestation. It is well known that pregnancy has an immunosuppressive effect on m...
L26/O-271 The clinical impact of the progesterone-to-estradiol ratio on blastocyst development is confined to low-estradiol IVF cycles
L26/O-271 The clinical impact of the progesterone-to-estradiol ratio on blastocyst development is confined to low-estradiol IVF cycles
Abstract
Study question
Does the progesterone-to-estradiol ratio predict good-quality blastocyst formation, and is its im...
Estradiol Concentrations and Wellbeing in Trans People Using Estradiol Hormone Therapy
Estradiol Concentrations and Wellbeing in Trans People Using Estradiol Hormone Therapy
Purpose:
In trans people undergoing feminizing hormone therapy, optimal estradiol concentrations are unclear, and anecdotally, some individuals desire supraphys...
The Hidden Problem of Cross-Reactivity: Challenges in HIV Testing During the COVID-19 Era: A Systematic Review
The Hidden Problem of Cross-Reactivity: Challenges in HIV Testing During the COVID-19 Era: A Systematic Review
Abstract
Introduction
Human immunodeficiency virus (HIV) and Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV2) surface glycoproteins, including shared epitope motifs, sho...
Evaluation of estriol levels in women with preeclampsia in Nnewi, South-East Nigeria
Evaluation of estriol levels in women with preeclampsia in Nnewi, South-East Nigeria
Preeclampsia is a life-threatening pregnancy-induced disorder characterized by the presence of hypertension and proteinuria occurring after 20 weeks of gestation in a previously no...
Estradiol Valerate/Dienogest: A Novel Oral Contraceptive
Estradiol Valerate/Dienogest: A Novel Oral Contraceptive
Objective: To review the pharmacology, pharmacokinetics, efficacy, and safety of the new oral contraceptive estradiol valerate/dienogest. Data Sources: Searches of PubMed (1966-Jul...
Estradiol during (analogue-) trauma: risk- or protective factor for intrusive re-experiencing?
Estradiol during (analogue-) trauma: risk- or protective factor for intrusive re-experiencing?
Intrusions, a key symptom of posttraumatic stress disorder (PTSD), can occur as classically conditioned responses to trauma-related cues, both in the form of images and pain sensat...
Abstract 1295: Regulation of PAX2 activity by estradiol in breast cancer cells
Abstract 1295: Regulation of PAX2 activity by estradiol in breast cancer cells
Abstract
Most breast cancer deaths arise from tumour cells ability to produce distant metastases. Among breast tumour subtypes, luminal A tumours, which express the ...

